MARCOS
GONZÁLEZ DÍAZ
Researcher in the period 1993-2023
Hospital Garcia de Orta
Almada, PortugalPublications in collaboration with researchers from Hospital Garcia de Orta (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477